期刊文献+

慢性乙肝患者外周血淋巴细胞与IDO相关性研究

The study of correlation between IDO and PBLC in chronic hepatitis
暂未订购
导出
摘要 目的观察慢性乙型肝炎(CHB)患者外周血淋巴细胞亚群的变化及其与吲哚胺2,3-二氧化酶(IDO)的相关性,探索CHB免疫低下的机制。方法采用随机对照方法,采集50例CHB患者及健康对照组外周静脉血3ml,分别用流式细胞仪检查其CD4+和CD8+T细胞,用荧光实时PCR检测IDO mRNA,比较两组淋巴细胞、IDO的差异及其相关性分析。结果 CHB患者外周血CD4+和CD8+T细胞均较对照组减少,尤以CD4+T细胞为甚;IDO mRNA较对照组明显增多,其与CD4+T细胞及CD4+/CD8+均呈负相关(r=-0.622和0.426,P<0.05)。结论 CHB患者细胞免疫功能低下,IDO的过度表达可能是其主要机制之一。 Objective To observe the correlation between T lymphocyte subsets and the expression of indoleamine-2,3-dioxide enzyme(IDO) so as to explore the role of IDO in immune suppression of chronic hepatitis B(CHB). Methods The peripheral venous blood samples were taken from 50 CHB patients and 50 healthy people as control group at random and then T lymphocyte subsets and IDO mRNA were detected using FCM and real-time PCR respectively.The difference of T lymphocyte subsets and IDO mRNA were compared between two groups and the correlations of T lymphocyte subsets and IDO mRNA in CHB patients were statistically analyzed. Results In CHB patients,the IDO mRNA was significantly more and CD4+,CD8+T lymphocyte as well as ratio of CD4+/CD8+ were all less than those in control group(P0.05).Additionally,IDO mRNA0 was negative correlated with CD4+ T cells(r=-0.622,P0.05) and ratio of CD4+/CD8+(r=-0.426,P0.05). Conclusion CHB patients have a weakened cellular immune function.IDO over-expression is probably responsible for the immunosuppression in CHB.
出处 《临床军医杂志》 CAS 2012年第6期1290-1293,共4页 Clinical Journal of Medical Officers
基金 中国博士后科学基金(No.20060390678)
关键词 吲哚胺2 3-二氧化酶 T细胞亚群 乙型肝炎 免疫 indoleamine-2 3-dioxide enzyme T-lymphocyte hepatitis B immune 9
  • 相关文献

参考文献1

二级参考文献30

  • 1Bertoletti A, Maini M, Williams R. Role of hepatitis B virus specific cytotoxic T ceils in liver damage and viral control.Antiviral Res 2003; 60:61-66.
  • 2Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R,Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25-36.
  • 3Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R,Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825-829.
  • 4Suri D, Schilling R, Lopes AR, Mullerova I, Colucci G, Williams R, Naoumov NV. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J Hepatol 2001; 35:790-797.
  • 5Lu M, Lohrengel B, Hilken G, Kemper T, Roggendorf M. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes. J Virol 2002: 76:58-67.
  • 6Schultz U, Chisari FV. Recombinant duck interferon-gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J Virol 1999; 73:3162-3168.
  • 7Cova L,Zoulim F. Duck hepatitis B virus model in the study of hepatitis B virus. Methods Mol Med 2004; 96:261-268.
  • 8Jilbert AR, Botten JA, Miller DS, Bertram EB, Hall PM,Kotlarski L, Burrel CJ. Characterization of age-and doserelated outcomes of duck hepatitis B virus infection. Virology 1998; 244:273-282.
  • 9Jilbert AR, Kotlarski I. Immune responses to duck hepatitis B virus infection. Dev Comp lmmunol 2000; 24:285-302.
  • 10Pertmer TM, Oran AE, Madorin CA, Robinson HL. Th1 genetic adjuvants modulate immune response in neonates. Vaccine 2001; 19:1764-1771.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部